Robert Frankfather, DPM
Podiatrist · Nashville, TNNPI 1053421941
Payments from drug & device makers
What this record shows
This record is dominated by other: $5,750 of the $8,105 with a category attached, or 70.9%. Convatec Inc. accounts for 72.4% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $6,554, more than ten times the $248 reported in 2019.
Across 45 payments — averaging $180.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$6K
- Organogenesis Inc.$2K
- Stryker$192
- Bioventus LLC$181
- Integra Lifesciences Corporation$132
- Osiris Therapeutics Inc.$88
- plus $88 from 3 others
What the payments were for
- Speaking & faculty fees$1171%
- Food & beverage$2,23828%
- Other$5,75071%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 2 | $5,871 |
| Organogenesis Inc. | 32 | $1,552 |
| Stryker(2 entities) | 3 | $192 |
| Bioventus LLC | 3 | $181 |
| Integra Lifesciences Corporation | 1 | $132 |
| Osiris Therapeutics Inc. | 1 | $88 |
| Lifenet Health | 1 | $33 |
| Amgen | 1 | $29 |
| Averitas Pharma Inc. | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$5,871
- INTEGRA$396
- Affinity$224
- Apligraf$206
- VIA MATRIX$134
- INTEGRA DERMAL REGENERATION TEMPLATE$132
- PRIMATRIX$132
- PuraPly$120
- Exogen Ultrasound Bone Healing System$112
- FIXOS$107
- VARIAX$107
- G-FORCE$107
- ICONIX$107
- Dermagraft$103
- Puraply/Affinity/NuTech$103
- PURAPLY WOUND MATRIX$103
How this compares
$8,105 in reported general payments places this provider in the 80th percentile of 105 podiatrist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 63 | $749 |
| Meloxicam | 58 | $173 |
| Clindamycin Hcl | 16 | $123 |
| Ciprofloxacin Hcl | 12 | $66 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Nashville
- Michael KingNashville$190K
- Adam HicksNashville$6K
- David TrennerNashville$3K
- Justin JexNashville$1K
- Paul SomersNashville$1000
- Jeffrey LovelandSparta$809K
- Penninah KumarMt Juliet$72K
- James HarrisTrenton$49K
- Matthew NeuhausSmyrna$33K
- Paul HutchisonMemphis$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.